
Join to View Full Profile
1441 Eastlake AveSte 7416Los Angeles, CA 90089
Phone+1 323-865-3700
Fax+1 323-865-0120
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Clinical Trials
- Cabozantinib in Patients With Locally Advanced or Metastatic Urothelial Cell Carcinoma. Start of enrollment: 2020 Feb 10
Publications & Presentations
PubMed
- 30 citationsUse of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.Georg Bartsch, Anirban P. Mitra, Sheetal A. Mitra, Arpit A. Almal, Kenneth Steven
The Journal of Urology. 2016-02-01 - 23 citationssE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.Igor Tsaur, Kristina Thurn, Eva Juengel, Kilian M. Gust, Hendrik Borgmann
Journal of Experimental & Clinical Cancer Research. 2015-05-14 - 63 citationsChemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (−)-Gossypol (AT-101)Jens Mani, Stefan Vallo, Stefanie Rakel, Patrick Antonietti, Florian Gessler
BMC Cancer. 2015-04-07